Диссертация (1335845), страница 41
Текст из файла (страница 41)
– 2000.- Vol. 62.- P. 1818-1822.398.Rice L.W. Estrogen receptor mRNA splice variants in pre- andpostmenopausal human endometrium and endometrial carcinoma / L.W. Rice,A.A. Jazaeri, M.A. Shupnik // Gynecol Oncol.- 1997.- Vol. 65.- P. 149-157.399.Effect of bright light and melatonin on cognitive and noncognitivefunction in elderly residents of group care facilities: a randomized controlledtrial / R.F. Riemersma-van der Lek [et al.] // JAMA.- 2008.
– Vol. 299.- P.2642-2655.400.Rinne J.O. Neuronal size and density in the human nucleus basalis ofMeynert in Alzheimer's disease / J.O. Rinne, L. Paljorvi, U.K. Rinne // J.Neurol. Sci. – 1987.- Vol. 79.- P. 67-76.272401.Ritchie K.
The dementias / K. Ritchie, S. Lovestone // Lancet.- 2002.-Vol. 360.- P. 1759-1766.402.Resistance to Alzheimer’s pathology is associated with nuclearhypertrophy in neurons / M.A. Riudavets [et al.] // Neurobiol. Aging.- 2007.Vol. 28.- P. 1484-1492.403.Roman G.C. Cholinergic dysfunction in vascular dementia / G.C. Roman// Curr. Psychiatry Rep.- 2005.- Vol.
7.- P. 18-26.404.Roman G.C. Facts, myths, and controversies in vascular dementia / G.C.Roman // J. Neurol. Sci.- 2004.- Vol. 226.- P. 49-52.405.Subcortical ischaemic vascular dementia / G.C. Roman [et al.] // LancetNeurol.- 2002.- Vol. 1.- P. 426-436.406.Roman G.C. Vascular determinants of cholinergic deficits inAlzheimer’s disease and vascular dementia / G.C. Roman, R.N. Kalaria //Neurobiol. Aging.- 2006.- Vol. 27.- P. 1769-1785.407.Vascular cognitive disorder: a new diagnostic category updating vascularcognitive impairment and vascular dementia / G.C.
Roman [et al.] // J. Neurol.Sci. – 2004.- Vol. 226.- P. 81-87.408.Vascular dementia: diagnostic criteria for research studies, Report of theNINCDS-AIREN International Workshop / G.C. Roman [et al.] // Neurology.1993.- Vol. 43.- P. 250-260.409.Stereological study of the ultrastructural changes induced by chronicalcohol consumption and dehydration in the supraoptic nucleus of the rathypothalamus / C. Ruela [et al.] // J. Neurocytol.- 1994.- Vol. 23.- P. 410-421.410.Sachdev P.S. Vascular dementia: diagnosis, management and possibleprevention / P.S.
Sachdev, H. Brodaty, J.C.L. Looi // Med. J. Aust.- 1999.Vol. 170.- P. 81-85.411.Testosteroneraisesneuropeptide-Yconcentrationinselectedhypothalamic sites and in vitro release from the medial basal hypothalamus of273castrated male rats / A. Sahu [et al.] // Endocrinology.- 1989.- Vol.
124.- P.410-414.412.De novo expression of aromatase in gastric carcinoma. Light andelectron microscopic immunohistochemical and immunoblot study / Y. Saitoh[et al.] // Pathol. Res. Pract.- 1992.- Vol. 188.- P. 53-60.413.Neurotensinimmunoreactivityinthehumancingulategyrus,hippocampal subiculum and mamillary bodies.
Its potential role in memoryprocessing / N. Sakamoto [et al.] // Brain Res.- 1986.- Vol. 375.- P. 351-356.414.Fragmentation of the Golgi apparatus of the ballooned neurons inpatients with corticobasal degeneration and Creutzfeldt-Jacob disease / A.Sakurai [et al.] // Acta Neuropathol.- 2000. –Vol. 100.
–P. 270-274.415.Sakurai A. Pathology of the inferior olivary nucleus in patients withmultiple system atrophy / A. Sakurai, K. Okamoto, M. Yaguchi // ActaNeuropathol.- 2002. –Vol. 103. –P. 550-554.416.Aggravated decrease in the activity of nucleus basalis neurons inAlzheimer’s disease is apolipoprotein E-type dependent / A. Salehi [et al.] //Proc.
Natl. Acad. Sci. USA.- 1998.- Vol. 95.- P. 11445-11449.417.Salehi A. A sex difference and no effect of ApoE type on the amount ofcytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer’sdisease / A. Salehi, V. Gonzalez Martinez, D.F. Swaab // Neurobiol Aging.1998.- Vol. 19.- P. 505-510.418.Decreased protein synthetic ability of the hypothalamic tuberomamillarynucleus in Alzheimer’s disease as suggested by the size of the Golgi apparatus/ A. Salehi [et al.] // Neurosci. Lett.- 1995.- Vol. 193.- P.
29-32.419.P75 Neurotrophin receptor in the nucleus basalis of Meynert in relationto age, sex and Alzheimer’s disease / A. Salehi [et al.] // Exp. Neurol.- 2000.Vol. 161.- P. 245-258.274420.Decreased activity of hippocampal neurons in Alzheimer’s disease is notrelated to the presence of neurofibrillary tangles / A. Salehi [et al.] // J.Neuropathol.
Exp. Neurol.- 1995b.- Vol. 54.- P. 704-709.421.Co-localization of high affinity neurotrophin receptors in nucleus basalisof Meynert neurons and their differential reduction in Alzheimer’s disease / A.Salehi [et al.] // Neuroscience.- 1996.- Vol. 75.- P. 373-387.422.Sangruchi T. NADPH diaphorase histochemistry of the humanhypothalamus / T. Sangruchi, N.W. Kowall // Neuroscience.- 1991.- Vol. 40.P. 713-724.423.Saper C.B. Hypothalamic pathology in Alzheimer’s disease / C.B. Saper,D.C.
German // Neurosci. Lett.- 1987.- Vol. 74.- P. 364-370.424.Saper C.B. A cytoarchitectonic and histochemical study of nucleusbasalis and associated cell groups in the normal human brain / C.B. Saper, T.C.Chelimsky // Neuroscience.- 1984.- Vol. 13.- P. 1023-1037.425.Saper C.B. Hypothalamus. In “The human nervous system”, ed. by G.Paxinos / C.B.Saper.- Academic Press, Inc., San Diego, 1990.- P.
389-413.426.Localization and developmental pattern of vasoactive intestinalpolypeptide binding sites in the human hypothalamus / A. Sarrieau [et al.] //Synapse.- 1994.- Vol. 17.- P. 129-140.427.Aromatase in the human central nervous system / H. Sasano [et al.] //Clin. Endocrinol.- 1998.- Vol. 48.- P. 325-329.428.Hippocampal estrogen receptor immunoreactivity is increased inAlzheimer’s disease / E. Savaskan [et al.] // Brain Res.- 2001.- Vol. 908.- P.113-119.429.Neuronal and non-neuronal aromatase in primary cultures of developingzebra finch telencephalon / B.A. Schlinger [et al.] // J.
Neurosci.- 1994.- Vol.14.- P. 7541-7552.275430.Schlinger B.A. Plasma sex steroids and tissue aromatization in hatchlingzebra finches: implications for the sexual differentiation of singing behavior /B.A. Schlinger, A.P. Arnold // Endocrinology.- 1992.- Vol. 130.- P. 289-299.431.Schmidt R. Comparison of magnetic resonance imaging in Alzheimer’sdisease, vascular dementia and normal aging / R. Schmidt // Eur. Neurol.1992.- Vol. 32.- P. 164-169.432.Effects of estrogen replacement therapy on response to tacrine in patientswith Alzheimer's disease / L.S. Schneider [et al.] // Neurology.- 1996.- Vol.46.- P. 1580-1584.433.Reduced cerebrospinal fluid estradiol levels are associated withincreased beta-amyloid levels in female patients with Alzheimer's disease / P.Schonknecht [et al.] // Neurosci.
Lett.- 2001.- Vol. 307.- P. 122-124.434.Long-time in vivo metabolic monitoring following experimental braincontusion using proton magnetic resonance spectroscopy / M.U. Schuhmann[et al.] // Acta Neurochir. Suppl.- 2002.- Vol. 81. –P. 209-212.435.Neurofibrillary pathology in the human paraventricular and supraopticnuclei / C.
Schultz [et al.] // Acta Neuropathol.- 1997.- Vol. 94.- P. 99-102.436.Seeman M.V. Psychopathology in women and men: focus on femalehormones / M.V. Seeman // Am. J. Psychiatry.-1997.- Vol. 154.- P. 1641-1647.437.SeidmanS.N. Testosterone and depression in ageing men / S.N.Seidman, B.T. Walsch // Am. J. Geriatr.
Psychiatry.- 1999.- Vol. 7.- P. 18-33.438.Selkoe D.J. Alzheimer’s disease: genes, proteins, and therapy / D.J.Selkoe // Physiol. Rev.- 2001.- Vol. 81.- P. 741-766.439.Postmenopausal estrogen replacement therapy and the risk ofAlzheimer’s disease / S. Seshadri [et al.] // Arch. Neurol.- 2001.- Vol. 58.- P.435-440.440.Role of peripheral and central aromatization in the control ofgonadotrophin secretion in the male sheep / T.P. Sharma [et al.] // Reprod.Fertil. Dev.- 1999.- Vol. 11.- P. 293-302.276441.Sharp P.A.
Classification of introns: U2-type or U12-type / P.A. Sharp,C.B.Burge // Cell.- 1997.- Vol. 91.- P. 875-879.442.Size of mamillary bodies in health and disease: useful measurements inneuroradiological diagnosis of Wernicke’s encephalopathy / D. Sheedy [et al.]// Alcohol Clin. Exp. Res.- 1999.- Vol. 23.- P. 1624-1628.443.Cloning of a gene bearing missense mutations in early-onset familialAlzheimer’s disease / K. Sherrington [et al.] // Nature.- 1995.- Vol. 375.- P.754-760.444.Sherwin B.B.
Estrogen and cognitive functioning in women / B.B.Sherwin // Endocr. Rev. – 2003.- Vol. 24.- P. 133-151.445.Elevated gonadotropin levels in patients with Alzheimer disease / R.A.Short [et al.] // Mayo Clin. Proc.- 2001.- Vol. 76.- P. 906-909.446.Shughrue P.J. Comparative distribution of estrogen receptor- and -mRNA in the rat central nervous system / P.J. Shughrue, M.V. Lane, I.J.Merchenthaler // Comp. Neurol.- 1997.- Vol.
388.- P. 507-525.447.Shughrue P.J. Estrogen binding and estrogen receptor characterization(ER and ER) in the cholinergic neurons of the rat basal forebrain / P.J.Shughrue, P.J. Scrimo, I. Merchenthaler // Neuroscience.- 2000.- Vol. 96.- P.41-49.448.Simonian N.A. Functional alterations in neural circuits in Alzheimer’sdisease / N.A. Simonian, B.T. Hyman // Neurobiol. Aging.- 1995.- Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
